See more : Aztech Global Ltd. (8AZ.SI) Income Statement Analysis – Financial Results
Complete financial analysis of Ilsung Pharmaceuticals Co., Ltd. (003120.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ilsung Pharmaceuticals Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Dispensa Group Plc (DISP.L) Income Statement Analysis – Financial Results
- Ace Software Exports Limited (ACESOFT.BO) Income Statement Analysis – Financial Results
- Nulab Inc. (5033.T) Income Statement Analysis – Financial Results
- S.P. Apparels Limited (SPAL.NS) Income Statement Analysis – Financial Results
- VIRIDIEN (CGPVF) Income Statement Analysis – Financial Results
Ilsung Pharmaceuticals Co., Ltd. (003120.KS)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.ilsung-ph.co.kr
About Ilsung Pharmaceuticals Co., Ltd.
Ilsung Pharmaceuticals Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, anti-coagulants, circulatory system drugs, contrast agents, diabetes treatments, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, anesthetics, antipyretics, and cardiovascular system products. Ilsung Pharmaceuticals Co., Ltd. was founded in 1954 and is headquartered in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 78.05B | 61.25B | 42.09B | 40.60B | 48.41B | 61.65B | 67.04B | 67.46B | 61.75B | 62.83B | 62.81B | 77.16B | 68.19B | 68.59B | 71.47B | 79.87B | 78.83B |
| Cost of Revenue | 43.34B | 33.31B | 25.95B | 27.42B | 30.25B | 39.06B | 40.80B | 42.47B | 39.58B | 41.51B | 41.73B | 55.89B | 43.73B | 44.09B | 40.70B | 42.84B | 37.03B |
| Gross Profit | 34.72B | 27.94B | 16.14B | 13.18B | 18.17B | 22.59B | 26.24B | 24.99B | 22.16B | 21.32B | 21.08B | 21.27B | 24.46B | 24.51B | 30.77B | 37.03B | 41.81B |
| Gross Profit Ratio | 44.48% | 45.61% | 38.33% | 32.47% | 37.52% | 36.65% | 39.15% | 37.04% | 35.89% | 33.93% | 33.57% | 27.56% | 35.87% | 35.73% | 43.05% | 46.36% | 53.03% |
| Research & Development | 1.52B | 1.51B | 99.08M | 109.21M | 93.49M | 131.82M | 303.96M | 237.14M | 318.93M | 212.55M | 417.76M | 881.33M | 1.07B | 1.17B | 1.12B | 544.20M | 415.48M |
| General & Administrative | 2.61B | 1.61B | 1.48B | 1.41B | 1.63B | 2.08B | 2.34B | 2.75B | 2.69B | 2.91B | 2.78B | 2.78B | 2.50B | 2.38B | 2.31B | 2.52B | 3.00B |
| Selling & Marketing | 20.17B | 13.17B | 7.67B | 4.58B | 7.61B | 7.89B | 10.49B | 9.09B | 6.71B | 5.82B | 6.37B | 5.56B | 6.60B | 6.48B | 6.12B | 5.68B | 6.47B |
| SG&A | 40.95B | 14.78B | 9.15B | 5.98B | 9.24B | 9.96B | 12.83B | 11.84B | 9.40B | 8.72B | 9.14B | 8.33B | 9.10B | 8.85B | 8.44B | 8.20B | 9.47B |
| Other Expenses | 0.00 | 10.34B | 8.69B | 9.04B | 10.09B | -343.24M | 147.48M | -226.87M | 124.65B | 894.36M | 8.54B | 47.05B | 42.55B | 173.56M | 310.78M | 421.34M | 2.54B |
| Operating Expenses | 42.47B | 26.64B | 17.93B | 15.13B | 19.42B | 20.34B | 23.65B | 22.54B | 19.57B | 18.89B | 19.71B | 19.95B | 20.22B | 20.02B | 18.63B | 18.79B | 21.35B |
| Cost & Expenses | 85.81B | 59.95B | 43.89B | 42.55B | 49.67B | 59.39B | 64.45B | 65.01B | 59.16B | 60.40B | 61.44B | 75.84B | 63.96B | 64.11B | 59.33B | 61.64B | 58.38B |
| Interest Income | 8.45B | 92.11B | 300.64M | 694.70M | 679.00M | 734.04M | 1.93B | 1.87B | 2.12B | 2.61B | 1.94B | 104.05M | 200.80M | 409.15M | 272.21M | 1.15B | 966.43M |
| Interest Expense | 23.87M | 12.63M | 12.63M | 13.88M | 5.45M | 10.00K | 6.00K | 0.00 | 399.00K | 278.00K | 21.64M | 94.14M | 199.97M | 47.06M | 174.00M | 317.45M | 33.26M |
| Depreciation & Amortization | 3.09B | 2.98B | 3.07B | 3.06B | 3.08B | 3.01B | 3.23B | 3.02B | 2.76B | 2.81B | 3.20B | 3.28B | 3.24B | 3.39B | 3.19B | 3.85B | 1.49B |
| EBITDA | -18.47B | 145.29B | 1.56B | 1.11B | 1.83B | 5.27B | 5.82B | 5.48B | 5.35B | 5.24B | 4.57B | 51.67B | 50.42B | 12.51B | 14.88B | 52.28B | 27.64B |
| EBITDA Ratio | -23.67% | 234.00% | 11.17% | 6.80% | 6.84% | 11.18% | 11.64% | 8.11% | 216.98% | 16.87% | 23.77% | 66.99% | 73.94% | 16.68% | 26.91% | 33.31% | 34.95% |
| Operating Income | -7.76B | 140.22B | 1.63B | -298.56M | 226.77M | 2.26B | 2.59B | 2.45B | 2.59B | 2.43B | 1.37B | 1.32B | 4.47B | 4.49B | 12.14B | 18.23B | 20.45B |
| Operating Income Ratio | -9.94% | 228.95% | 3.87% | -0.74% | 0.47% | 3.66% | 3.86% | 3.64% | 4.19% | 3.87% | 2.18% | 1.71% | 6.56% | 6.54% | 16.98% | 22.83% | 25.94% |
| Total Other Income/Expenses | -13.59B | 2.07B | -1.07B | 6.36B | 10.44B | 2.33B | 1.99B | 1.55B | 128.43B | 5.48B | 9.60B | 46.97B | 42.51B | 4.59B | -628.00M | 29.88B | 5.67B |
| Income Before Tax | -21.34B | 137.97B | -1.52B | 4.42B | 9.18B | 4.59B | 4.58B | 4.99B | 131.02B | 7.91B | 10.98B | 48.29B | 46.98B | 9.07B | 11.51B | 48.12B | 26.12B |
| Income Before Tax Ratio | -27.35% | 225.27% | -3.62% | 10.88% | 18.96% | 7.44% | 6.83% | 7.39% | 212.19% | 12.58% | 17.47% | 62.59% | 68.89% | 13.23% | 16.10% | 60.25% | 33.13% |
| Income Tax Expense | -404.04M | 32.73B | -155.82M | 1.20B | 2.46B | 1.64B | 1.95B | 1.97B | 32.17B | 3.87B | 3.02B | 11.84B | 11.90B | 2.78B | 3.46B | 13.96B | 8.42B |
| Net Income | -20.94B | 108.67B | -1.37B | 3.22B | 6.72B | 2.95B | 2.63B | 3.02B | 98.85B | 4.03B | 7.96B | 36.45B | 35.08B | 6.30B | 8.05B | 34.16B | 17.70B |
| Net Income Ratio | -26.83% | 177.43% | -3.25% | 7.93% | 13.88% | 4.78% | 3.92% | 4.47% | 160.10% | 6.42% | 12.67% | 47.24% | 51.45% | 9.18% | 11.26% | 42.77% | 22.45% |
| EPS | -2.99K | 2.91K | -178.32 | 419.91 | 971.73 | 438.40 | 391.20 | 449.00 | 14.71K | 600.40 | 1.18K | 5.28K | 4.82K | 740.20 | 843.00 | 2.81K | 1.34K |
| EPS Diluted | -2.99K | 2.91K | -178.32 | 419.91 | 971.73 | 438.40 | 391.20 | 449.00 | 14.71K | 600.40 | 1.18K | 5.28K | 4.82K | 740.20 | 843.00 | 2.81K | 1.34K |
| Weighted Avg Shares Out | 6.99M | 37.39M | 7.67M | 7.67M | 6.91M | 6.72M | 6.72M | 6.72M | 6.72M | 6.72M | 6.77M | 6.90M | 7.27M | 8.51M | 9.55M | 12.16M | 13.21M |
| Weighted Avg Shares Out (Dil) | 6.99M | 37.39M | 7.67M | 7.67M | 6.91M | 6.72M | 6.72M | 6.72M | 6.72M | 6.72M | 6.77M | 6.90M | 7.27M | 8.51M | 9.55M | 12.16M | 13.21M |
Source: https://incomestatements.info
Category: Stock Reports